Kết quả tìm kiếm - Seelig, Eleonora
- Đang hiển thị 1 - 9 kết quả của 9
-
1
-
2
Neuroendocrine Regulation and Metabolism of Glucose and Lipids in Primary Chronic Insomnia: A Prospective Case-Control Study Bằng Seelig, Eleonora, Keller, Ulrich, Klarhöfer, Markus, Scheffler, Klaus, Brand, Serge, Holsboer-Trachsler, Edith, Hatzinger, Martin, Bilz, Stefan
Được phát hành 2013Text -
3
-
4
Exercise and the dipeptidyl‐peptidase IV inhibitor sitagliptin do not improve beta‐cell function and glucose homeostasis in long‐lasting type 1 diabetes—A randomised open‐label stu... Bằng Seelig, Eleonora, Trinh, Beckey, Hanssen, Henner, Schmid‐Trucksäss, Arno, Ellingsgaard, Helga, Christ‐Crain, Mirjam, Donath, Marc Y.
Được phát hành 2019Text -
5
IL-6 Receptor Blockade Increases Circulating Adiponectin Levels in People with Obesity: An Explanatory Analysis Bằng Wueest, Stephan, Seelig, Eleonora, Timper, Katharina, Lyngbaek, Mark P., Karstoft, Kristian, Donath, Marc Y., Ellingsgaard, Helga, Konrad, Daniel
Được phát hành 2021Text -
6
Effectiveness of a personal health coaching intervention (diabetescoach) in patients with type 2 diabetes: protocol for an open-label, pragmatic randomised controlled trial Bằng Hohberg, Vivien, Kreppke, Jan-Niklas, Kohl, Jan, Seelig, Eleonora, Zahner, Lukas, Streckmann, Fiona, Gerber, Markus, König, Daniel, Faude, Oliver
Được phát hành 2022Text -
7
SAT-059 Treatment Of Primary Aldosteronism With The mTORC1 Inhibitor Everolimus Bằng Trinh, Beckey, Hepprich, Matthias, Betz, Matthias, Burkard, Thilo, Cavelti.Weder, Claudia, Seelig, Eleonora, Meienberg, Fabian, Kratschmar, Denise, Odermatt, Alex, Michael, Hall, Donath, Marc, Swierczynska, Marta
Được phát hành 2019Text -
8
Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes Bằng Cavelti-Weder, Claudia, Timper, Katharina, Seelig, Eleonora, Keller, Cornelia, Osranek, Martin, Lässing, Ute, Spohn, Gunther, Maurer, Patrik, Müller, Philipp, Jennings, Gary T, Willers, Joerg, Saudan, Philippe, Donath, Marc Y, Bachmann, Martin F
Được phát hành 2016Text -
9
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes Bằng Seelig, Eleonora, Howlett, James, Porter, Linsey, Truman, Lucy, Heywood, James, Kennet, Jane, Arbon, Emma L., Anselmiova, Katerina, Walker, Neil M., Atkar, Ravinder, Pekalski, Marcin L., Rytina, Ed, Evans, Mark, Wicker, Linda S., Todd, John A., Mander, Adrian P., Bond, Simon, Waldron-Lynch, Frank
Được phát hành 2018Text